Logo

Reduction in length of immunotherapy treatment for hard-to-treat melanoma shows promise in clinical trial

Reduction in length of immunotherapy treatment for hard-to-treat melanoma shows promise in clinical trial

Reducing the length of immunotherapy treatment for an advanced skin cancer did not significantly diminish disease control when compared to giving treatments over a longer period, according to research led by the Universities of Sheffield and Leeds and Sheffield Teaching Hospitals NHS Foundation Trust.

👉 Full Story